Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1800]

Rituximab-based chemotherapy achieves strong outcomes without routine...

Dr Konstantinos Christofyllakis - Saarland University, Saarbrücken, Germany

Rituximab-based chemotherapy achieves strong outcomes without routine radiotherapy in stage I extranodal large B-cell lymphoma ( Dr Konstantinos Christofyllakis - Saarland University, Saarbrücken, Germany )

Durvalumab plus chemotherapy improves outcomes and urine tumour DNA predicts...

Dr Michiel van der Heijden - Netherlands Cancer Institute, Amsterdam...

Durvalumab plus chemotherapy improves outcomes and urine tumour DNA predicts response in muscle-invasive bladder cancer ( Dr Michiel van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )

Zolbetuximab plus nivolumab and chemotherapy shows promising responses in...

Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan

Zolbetuximab plus nivolumab and chemotherapy shows promising responses in CLDN18.2-positive metastatic gastric cancer ( Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan )

EAU 2026: Updates in NMIBC

Dr Francesco Soria, Prof Jonathan Aning, Dr Antoni Vilaseca and Prof Alexandra...

EAU 2026: Updates in NMIBC ( Dr Francesco Soria, Prof Jonathan Aning, Dr Antoni Vilaseca and Prof Alexandra Masson-Lecomte )

Circulating tumour DNA shows high accuracy for monitoring testicular cancer...

Dr Dalia Kaakour - University of California, Irvine, USA

Circulating tumour DNA shows high accuracy for monitoring testicular cancer across all stages ( Dr Dalia Kaakour - University of California, Irvine, USA )

Pembrolizumab plus belzutifan improves disease-free survival in high-risk...

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Pembrolizumab plus belzutifan improves disease-free survival in high-risk kidney cancer after surgery ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Durvalumab plus tremelimumab temporarily reduces QoL in resected renal cell...

Dr Sophie Merrick - University College London, London, UK

Durvalumab plus tremelimumab temporarily reduces QoL in resected renal cell carcinoma patients ( Dr Sophie Merrick - University College London, London, UK )

Patients with non-metastatic HSPC prefer ARPI-based therapy over androgen...

Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA

Patients with non-metastatic HSPC prefer ARPI-based therapy over androgen deprivation alone ( Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA )

Enzalutamide plus leuprolide achieves durable PSA suppression after treatment...

Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA

Enzalutamide plus leuprolide achieves durable PSA suppression after treatment suspension ( Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA )

Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows...

Dr Karie Runcie - Columbia University, New York, USA

Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC ( Dr Karie Runcie - Columbia University, New York, USA )

ASCO GU 2026: Updates in renal cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ASCO GU 2026: Updates in renal cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

ASCO GU 2026: Updates in bladder cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ASCO GU 2026: Updates in bladder cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

More from ecancer